Latest Biotech News

Swiss Rockets secured an exclusive license from MGI Tech and Complete Genomics for CoolMPS sequencing chemistry outside the Asia‑Pacific region, positioning the Basel‑based incubator to develop...

Qiagen agreed to acquire Parse Biosciences for up to $280 million, folding a high‑throughput single‑cell library prep and automation provider into a larger public company. Parse’s founders and...

Large analyses presented at major nephrology meetings and published in JAMA reinforce that SGLT2 inhibitors provide kidney protection across a wide spectrum of patients, including people with and...

Eledon Pharmaceuticals reported Phase 2 Bestow results for tegoprubart (tego), a CD40‑ligand targeting therapy for preventing rejection in de novo kidney transplant patients, and the study failed...

The Chan‑Zuckerberg Biohub absorbed EvolutionaryScale’s team and assets to create an integrated AI‑biology initiative that centralizes frontier compute, experimental platforms, and data...

An elderly patient dosed with Intellia Therapeutics’ in vivo CRISPR candidate nexiguran ziclumeran (nex‑z) died after developing severe liver dysfunction, prompting the biotech to pause dosing and...

The Centers for Medicare & Medicaid Services announced a five‑year voluntary drug payment model for state Medicaid programs that aims to tie Medicaid outpatient drug prices to selected...

The U.S. Food and Drug Administration disclosed a second wave of Commissioner’s National Priority Vouchers (CNPVs), accelerating review for selected drug candidates aligned with administration...

President Trump announced agreements with Novo Nordisk and Eli Lilly to expand access and lower prices for their obesity medicines; the administration said the deals will lower costs for some...

PacBio said Berry Genomics received National Medical Products Administration Class III approval for the Sequel II CNDx system, marking what PacBio called the first regulatory clearance for a...

Gilead Sciences reported that Trodelvy failed to meet the primary endpoint in a Phase 3 trial for a subset of breast cancer patients, representing a significant setback for the antibody‑drug...

Researchers at MIT described a new ionizable lipid nanoparticle (LNP) that improved mRNA delivery potency in mice, enabling an influenza mRNA vaccine to elicit comparable immune responses at...

Qiagen announced an agreement to acquire Seattle‑based Parse Biosciences for up to $280 million, folding a high‑throughput single‑cell library prep company into a larger public instrument and...

Novo Nordisk raised its offer for obesity biotech Metsera in a contested sale that also drew a formal staff letter from the Federal Trade Commission raising concerns about the transaction’s...

Evommune, a clinical‑stage inflammation biotech with late‑stage data in chronic inducible urticaria, priced an initial public offering for approximately $150 million and began trading on the NYSE....

Intellia Therapeutics reported the death of a patient who had been hospitalized with liver injury after receiving nex‑z, its LNP‑delivered in vivo CRISPR base‑editing therapy for transthyretin...

The Trump administration struck agreements with Novo Nordisk and Eli Lilly to lower prices and expand access to leading obesity drugs and announced plans for a government drug portal. In parallel,...

Novo Nordisk continued to raise its bid for obesity biotech Metsera amid a heated auction with Pfizer, and the Federal Trade Commission flagged concerns about the structure of Novo’s proposal. FTC...

Eli Lilly disclosed Phase 2 data linking its amylin receptor agonist eloralintide to up to 20.1% mean weight loss at 48 weeks and announced plans to start Phase 3. The data showed dose‑dependent...

Arima Genomics touted results from its Aventa Hi‑C lymphoma assay that detected clinically significant gene fusions and structural rearrangements in FFPE lymphoma samples where FISH was...